Zyprexa, atypical antipsychotic medication with proven safety and efficacy

Published: 2004-09-10 06:58:00

Updated: 2004-09-10 06:58:00

The Korean College of Neuropsychopharmacology said it held on September 3 its autumn symposium for Zyprexa (olanzapine), a psychotropic medication indicated for the treatment of acute manic episodes associated with bipolar I disorder, which was sponsored by Lilly Korea in commemoration of Zyprexa's 7-year launching in Korea.

At that symposium, the following lecturers discussed the safety an...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.